Patterns and predictors of recurrence after radical resection of thymoma

来源 :2015年北京放射肿瘤年会 | 被引量 : 0次 | 上传用户:Mickey123
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: Recurrence of thymomas even after complete resection is common, but the relapse patterns remain controversial.This study aimed to define the patterns and predictors of relapse after complete resection of thymoma.Methods: A single-institution retrospective study was performed with 331 patients who underwent radical resection of thymoma between 1991 and 2012.Results: After a median follow-up of 59 months, the recurrence rate was 6.9% (23/331).Relapse occurred in 23 patients with the pleura (14) and tumor bed (6) as the most common sites of recurrence.According to the definitions of the International Thymic Malignancy Interest Group, 10 (43.5%) patients had local relapse, 15 (65.2%) had regional relapse, 10 (43.5%) had distant relapse.The difference in survival following relapse between lung and regional relapse was statistically significant (P =0.027) but that between lung and distant relapse was not (P=0.808).The recurrence rates correlated with the initial Masaoka stage.Further, recurrence also correlated with World Health Organization (WHO) tumor type.The recurrence-free survival rates in patients with tumor size ≥8 cm were worse than those of patients with tumor size <8 cm (P=0.007).Tumor size was also correlated with stage (r=0.110).As tumor becomes larger, the stage is more advanced (P=0.023).Multivariate analysis showed that Masaoka stage (P=0.005), tumor size (P=0.033), and WHO histological type (P=0.046) were predictive factors of relapse.Conclusion: Regional recurrence is the most common relapse pattern but local and distant relapse are also common.Advanced Masaoka stage, larger tumor size, and type B3 are risk factors of recurrence.Lung relapse should be considered distant relapse.Further, tumor size was correlated with Masaoka stage and therefore should be considered in the staging system.
其他文献
会议
会议
染色质解旋酶/ATP酶的DNA结合蛋白1样基因(CHD1L)是一种新近被证实与在许多实体瘤中表达增多的致癌基因,它定位于第1号染色体q21区.CHD1L在肝细胞癌和其他肿瘤中的功能性研究提示,该基因在肿瘤形成过程中可以引起细胞增殖、调节G1/S过渡期并且可以抑制细胞凋亡.CHD1L活化的潜在机制可能是通过结合凋亡蛋白Nur77,或通过上调CHD1L调控的靶基因(如ARHGEF9、SPOCK1或TC
To evaluate the efficacy and safety of 125I seeds implantation for refractory chest wall (CW)metastasis or recurrence under CT guidance.In addition we assessed initial data obtained on the therapeutic
会议
会议
Background: For patients with locally advanced non-small-cell lung cancer (LA-NSCLC), the role of consolidation chemotherapy (CCT) following concurrent chemoradiotherapy (CRT) is partially defined.The
Background: The aim of this study was to investigate the clinical characteristics and outcomes of patients with primary malignant mediastinal non-seminomatous germ cell tumor (MMNSGCT) by comparing th
保留功能的手术结合放疗是躯干四肢软组织肉瘤标准的综合治疗模式.术后放疗能够防止局部复发,对于高危患者还能延长生存期,是目前应用最广泛的辅助治疗方法,但长期纤维化、水肿、关节僵硬的发生率较高.术前放疗的局部控制率和总生存率与术后放疗相似,但手术后切口并发症发生率较高.在术前和术后放疗中采用调强放疗技术,能最大限度地保护正常组织,减少治疗后的并发症,维持良好的肢体功能.
Objective This study aimed to (1)compare the agreement of two evaluation methods of metabolic response in patients with non-small cell lung cancer (NSCLC) and determine their prognostic value and (2)